| Year |
Citation |
Score |
| 2024 |
Isayeva U, Manchia M, Collu R, Primavera D, Deriu L, Caboni E, Iaselli NM, Sundas D, Tusconi M, Pinna F, Paribello P, Scherma M, Pisanu C, Meloni A, Zai CC, et al. Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data. Schizophrenia Research. 266: 197-204. PMID 38422890 DOI: 10.1016/j.schres.2024.02.019 |
0.621 |
|
| 2022 |
Manchia M, Isayeva U, Collu R, Primavera D, Deriu L, Caboni E, Iaselli MN, Sundas D, Tusconi M, Pinna F, Paribello P, Scherma M, Pisanu C, Meloni A, Zai CC, et al. Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders. Brain Sciences. 12. PMID 36552127 DOI: 10.3390/brainsci12121666 |
0.731 |
|
| 2022 |
Isayeva U, Manchia M, Collu R, Primavera D, Deriu L, Caboni E, Iaselli N, Sundas D, Tusconi M, Pinna F, Paribello P, Scherma M, Pisanu C, Meloni A, Zai CC, et al. Exploring the association between brain-derived neurotrophic factor (BDNF) levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-19. PMID 36281033 DOI: 10.1192/j.eurpsy.2022.2333 |
0.675 |
|
| 2022 |
Zhao NO, Topolski N, Tusconi M, Salarda EM, Busby CW, Lima CNNC, Pillai A, Quevedo J, Barichello T, Fries GR. Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications. Brain, Behavior, & Immunity - Health. 21: 100441. PMID 35308081 DOI: 10.1016/j.bbih.2022.100441 |
0.439 |
|
| 2022 |
Natale A, Mineo L, Fusar-Poli L, Aguglia A, Rodolico A, Tusconi M, Amerio A, Serafini G, Amore M, Aguglia E. Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments. Brain Sciences. 12. PMID 35053835 DOI: 10.3390/brainsci12010092 |
0.267 |
|
| 2022 |
Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophrenia Research. 239: 34-41. PMID 34839071 DOI: 10.1016/j.schres.2021.11.023 |
0.65 |
|
| 2020 |
Carpiniello B, Tusconi M, Zanalda E, Di Sciascio G, Di Giannantonio M. Psychiatry during the Covid-19 pandemic: a survey on mental health departments in Italy. Bmc Psychiatry. 20: 593. PMID 33327940 DOI: 10.1186/s12888-020-02997-z |
0.512 |
|
| 2020 |
Lasalvia A, Vita A, Bellomo A, Tusconi M, Favaretto G, Bonetto C, Zanalda E, Mencacci C, Carpiniello B. Renaming schizophrenia? A survey among psychiatrists, mental health service users and family members in Italy. Schizophrenia Research. PMID 32593734 DOI: 10.1016/J.Schres.2020.03.047 |
0.581 |
|
| 2020 |
Carpiniello B, Tusconi M, di Sciascio G, Zanalda E, di Giannantonio M. Mental health services in Italy during the Covid-19 Pandemic. Psychiatry and Clinical Neurosciences. PMID 32515525 DOI: 10.1111/Pcn.13082 |
0.541 |
|
| 2020 |
Solinas A, Paoletti G, Firinu D, Di Pino M, Tusconi M, Mura JF, Del Giacco S, Marongiu F. Vaping effects on asthma: results from a web survey and clinical investigation. Internal and Emergency Medicine. PMID 31960343 DOI: 10.1007/S11739-019-02247-5 |
0.34 |
|
| 2019 |
Manchia M, Deriu L, Tusconi M, Primavera D, Caboni E, Iaselli N, Sundas D, Collu R, Scherma M, Congiu D, Squassina A, Fratta W, Fadda P, Carpiniello B. Clinical and genetic determinants of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: A longitudinal prospective study European Neuropsychopharmacology. 29: S133-S134. DOI: 10.1016/J.Euroneuro.2018.11.245 |
0.701 |
|
| 2017 |
Primavera D, Manchia M, Deriu L, Tusconi M, Collu R, Scherma M, Fadda P, Fratta W, Carpiniello B. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study. Bmj Open. 7: e014938. PMID 28550022 DOI: 10.1136/Bmjopen-2016-014938 |
0.73 |
|
| 2017 |
Manchia M, Primavera D, Deriu L, Tusconi M, Collu R, Scherma M, Fadda P, Fratta W, Carpiniello B. The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study European Neuropsychopharmacology. 27: S913. DOI: 10.1016/S0924-977X(17)31624-3 |
0.7 |
|
| 2016 |
Pinna F, Tusconi M, Dessì C, Pittaluga G, Fiorillo A, Carpiniello B. Violence and mental disorders. A retrospective study of people in charge of a community mental health center. International Journal of Law and Psychiatry. PMID 27180213 DOI: 10.1016/J.Ijlp.2016.02.015 |
0.592 |
|
| 2016 |
Murru A, Manchia M, Tusconi M, Carpiniello B, Pacchiarotti I, Colom F, Vieta E. Diagnostic reliability in schizoaffective disorder. Bipolar Disorders. 18: 78-80. PMID 26877101 DOI: 10.1111/Bdi.12366 |
0.7 |
|
| 2016 |
Tusconi M. Psychiatric Illnesses and Poisonings in Adolescents in the Emergency Department Acta Psychopathologica. 2. DOI: 10.4172/2469-6676.100042 |
0.271 |
|
| 2016 |
Primavera D, Manchia M, Tusconi M, Deriu L, Collu R, Scherma M, Fadda P, Fratta W, Carpiniello B. BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders European Neuropsychopharmacology. 26: S365-S366. DOI: 10.1016/S0924-977X(16)31305-0 |
0.685 |
|
| 2015 |
Pinna F, Fiorillo A, Tusconi M, Guiso B, Carpiniello B. Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy. International Journal of Mental Health Systems. 9: 37. PMID 26526168 DOI: 10.1186/S13033-015-0030-X |
0.642 |
|
| 2015 |
Pinna F, Deriu L, Diana E, Perra V, Randaccio RP, Sanna L, Tusconi M, Carpiniello B. Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders. Annals of General Psychiatry. 14: 6. PMID 25699085 DOI: 10.1186/S12991-015-0042-6 |
0.632 |
|
| 2015 |
Melis G, Pia G, Piras I, Tusconi M. Mental disorders and HIV infection in the emergency department: epidemiology and gender differences. Internal and Emergency Medicine. 10: 465-9. PMID 25537441 DOI: 10.1007/S11739-014-1175-3 |
0.444 |
|
| 2015 |
Pinna F, Deriu L, Diana E, Perra V, Randaccio PP, Sanna L, Tusconi M, Carpiniello B, Aru D, Bandecchi C, Corda E, Fatteri F, Ghiani A, Lai A, Lai S, et al. Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders Annals of General Psychiatry. 14. DOI: 10.1186/s12991-015-0042-6 |
0.623 |
|
| 2013 |
Pinna F, Tusconi M, Bosia M, Cavallaro R, Carpiniello B. Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders. Bmc Psychiatry. 13: 235. PMID 24294839 DOI: 10.1186/1471-244X-13-235 |
0.635 |
|
| 2013 |
Pinna F, Deriu L, Lepori T, Maccioni R, Milia P, Sarritzu E, Tusconi M, Carpiniello B. Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders. Psychiatry Research. 210: 739-44. PMID 24007858 DOI: 10.1016/J.Psychres.2013.08.022 |
0.641 |
|
| 2012 |
Carpiniello B, Pinna F, Tusconi M, Zaccheddu E, Fatteri F. Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study. Schizophrenia Research and Treatment. 2012: 576369. PMID 22966440 DOI: 10.1155/2012/576369 |
0.643 |
|
| Show low-probability matches. |
